At Elastrin, there‘s something new every day.

Elastrin Therapeutics Inc. closes $10M Funding Round

The previous article discussed the potential but also the struggles faced by development of therapies in the regenerative medicine...

We just recently got interviewed by the South Carolina Radio about Elastrin Therapeutics and our InnoVision Award win. Listen now to the...

GREENVILLE, S.C.--(BUSINESS WIRE)--Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to...

Regenerative Medicine is an interdisciplinary field that applies engineering and life science techniques to promote the repair or regrowth..

The cardiovascular system is an extremely dynamic environment, and its performance heavily relies on the synergies of its main players....

We are proud to present that Elastrin Therapeutics has won the 2021 InnoVision Technology Development Award. InnoVision Awards,...

CLEMSON, S.C. & BERLIN--(BUSINESS WIRE)--Elastrin is a biotechnology startup leveraging a platform technology to develop therapeutics...

A new approach to preventing the most severe outcomes of lung diseases, including COVID-19, has been developed by Elastrin Therapeutics Inc.

Clemson University researchers published pre-clinical proof of reversing in lab animals the leading cause of cardiovascular events in...

Elastrin's Chief Scientific Officer Prof. Naren Vyavahare was granted USD 2.2 million from the National Institutes of Health to advance...

The South Carolina Research Authority (SCRA) has granted Elastrin $25.000 in financial support through its Academic Start-up Assistance...

Elastrin Therpapeutics has won the 2018 Xi´an International Entrepreneuship Competition held in Hamburg October 19, 2018 and was selected...